(Q41610123)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

review article

1 reference

title

Role of cytokines in sepsis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

0 references

C E Hack

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L A Aarden

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

L G Thijs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Advances in Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

101-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

Pathophysiology of bacteremia

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The cardiovascular response of normal humans to the administration of endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL6 signalling through IL6 receptor and receptor-associated signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 and its receptor: a paradigm for cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cachectin: more than a tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of cachectin/TNF in endotoxic shock and cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The pathogenesis of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Management of septic shock: present and future

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Studies on the role of tumor necrosis factor in adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification of cachectin, a lipoprotein lipase-suppressing hormone secreted by endotoxin-induced RAW 264.7 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta)

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure of tumour necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Relaxed specificity of matrix metalloproteinases (MMPS) and TIMP insensitivity of tumor necrosis factor-alpha (TNF-alpha) production suggest the major TNF-alpha converting enzyme is not an MMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

In vitro processing of human tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human interleukin 1. Purification to homogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification and partial biochemical characterization of normal human interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nucleotide sequence of human monocyte interleukin 1 precursor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Modalities for reducing interleukin 1 activity in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Role of interleukin-1 in infectious diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of a monocyte specific pre-interleukin 1 beta convertase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning of the interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Crystal structure of the cysteine protease interleukin-1 beta-converting enzyme: a (p20/p10)2 homodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure and mechanism of interleukin-1 beta converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cell suicide: by ICE, not fire.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Key mediator takes shape

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A synthetic inhibitor of interleukin-1 beta converting enzyme prevents endotoxin-induced interleukin-1 beta production in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning and characterization of a new isoform of the interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

1 reference

7 January 2021

Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of a receptor for human tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogenous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Mapping the domain(s) critical for the binding of human tumor necrosis factor-alpha to its two receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A human tumor necrosis factor (TNF) alpha mutant that binds exclusively to the p55 TNF receptor produces toxicity in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A human tumor necrosis factor p75 receptor agonist stimulates in vitro T cell proliferation but does not produce inflammation or shock in the baboon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Two high-affinity interleukin 1 receptors represent separate gene products

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of interleukin-1 in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The two interleukin-1 receptors play different roles in IL-1 actions.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The type II 'decoy' receptor: a novel regulatory pathway for interleukin 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Degradation of interleukin 1beta by matrix metalloproteinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular Cloning and Expression of Human and Rat Tumor Necrosis Factor Receptor Chain (p60) and Its Soluble Derivative, Tumor Necrosis Factor-Binding Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Polymorphonuclear granulocytes enhance lipopolysaccharide-induced soluble p75 tumor necrosis factor receptor release from mononuclear cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification and characterization of a novel soluble receptor for interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL-1 receptor antagonist release is regulated differently in human alveolar macrophages than in monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumour necrosis factor-alpha: its role in the metabolic response to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The glucocorticoid antagonist RU38486 mimics interleukin-1 in its sensitization to the lethal and interleukin-6-inducing properties of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Adrenalectomy sensitizes mice to the lethal effects of interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Dysregulation of in vitro cytokine production by monocytes during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 potentiates the lethal effect of tumor necrosis factor alpha/cachectin in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

TNF modulates endothelial properties by decreasing cAMP

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transcriptional regulation of tissue factor expression in human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Lymphocyte function-associated antigen-1 (LFA-1) interaction with intercellular adhesion molecule-1 (ICAM-1) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokines as communication signals between leukocytes and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-alpha, LPS, and IL-1 beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prostacyclin synthesis induced in vascular cells by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transcriptional regulation of the endothelin-1 gene by TNF-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Recombinant human tumor necrosis factor-alpha. Regulation of N-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Expression of human neutrophil L-selectin during the systemic inflammatory response syndrome is partly mediated by tumor factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide amplifies interleukin 1-induced cyclooxygenase-2 expression in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Shock and tissue injury induced by recombinant human cachectin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Release of soluble intercellular adhesion molecule 1 into bile and serum in murine endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1-induced pathophysiology: induction of cytokines, development of histopathologic changes, and immunopharmacologic intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Morphologic changes in lungs of anesthetized sheep following intravenous infusion of recombinant tumor necrosis factor alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor causes increased pulmonary permeability and edema. Comparison to septic acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Leukocyte CD11b/18 antigen-directed monoclonal antibody improves early survival and decreases hypoxemia in dogs challenged with tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte depletion prevents tumor necrosis factor-mediated acute lung injury in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inflammation-induced expression of sialyl Lewis X-containing glycan structures on alpha 1-acid glycoprotein (orosomucoid) in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of coagulation after administration of tumor necrosis factor to normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Fibrinolytic response to tumor necrosis factor in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effects of interleukins on plasma arginine vasopressin and oxytocin levels in conscious, freely moving rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin and tumor necrosis factor-alpha-induced interleukin-8 release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor is involved in the appearance of interleukin-1 receptor antagonist in endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Complement activation and high-dose of interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor/cachectin. Induction of hemorrhagic necrosis in normal tissue requires the fifth component of complement (C5).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antagonism or transforming growth factor beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokine-stimulated nitric oxide production inhibits mitochondrial activity in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor-alpha induces a biphasic effect on myocardial contractility in conscious dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-tumor necrosis factor-alpha prevents decreased ventricular contractility in endotoxemic pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neuroendocrine, sympathetic and metabolic responses induced by interleukin-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Detection of circulating tumor necrosis factor after endotoxin administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Detection of interleukin 8 and tumor necrosis factor in normal humans after intravenous endotoxin: the effect of antiinflammatory agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The acute splanchnic and peripheral tissue metabolic response to endotoxin in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pretreatment with ibuprofen augments circulating tumor necrosis factor-alpha, interleukin-6, and elastase during acute endotoxinemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Oxpentifylline in endotoxaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Brief report: shock and multiple-organ dysfunction after self-administration of Salmonella endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Ibuprofen attenuates plasma tumor necrosis factor activity during sepsis-induced acute lung injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Detection of tumor necrosis factor soluble receptor p55 in blood samples from healthy and endotoxemic humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Production of interleukin-1-receptor antagonist during experimental endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin infusion in anesthetized sheep is associated with intrapulmonary sequestration of leukocytes that immunohistochemically express tumor necrosis factor-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Thrombomodulin release in baboon sepsis: its dependence on the dose of Escherichia coli and the presence of tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Platelet-activating factor or a platelet-activating factor antagonist decreases tumor necrosis factor-alpha in the plasma of mice treated with endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: improved survival and organ function

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 attenuates the release of proinflammatory cytokines but depresses splenocyte functions in murine endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pathogenesis of the toxic shock syndrome: T cell mediated lethal shock caused by the superantigen TSST-1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pentoxifylline improves survival and reduces tumor necrosis factor, interleukin-6, and endothelin-1 in fulminant intra-abdominal sepsis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The production of cytokines by polymorphonuclear neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prevention of endotoxin shock by an antibody against leukocyte integrin beta 2 through inhibiting production and action of TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 contributes to increased concentrations of soluble tumor necrosis factor receptor type I in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Efficacy of a monoclonal antibody directed against tumor necrosis factor in protecting neutropenic rats from lethal infection with Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protection against rat endotoxic shock by p55 tumor necrosis factor (TNF) receptor immunoadhesin: comparison with anti-TNF monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Glycosylated recombinant human tumor necrosis factor binding protein-1 reduces mortality, shock, and production of tumor necrosis factor in rabbit Escherichia coli sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transgenic mice expressing high levels of soluble TNF-R1 fusion protein are protected from lethal septic shock and cerebral malaria, and are highly sensitive to Listeria monocytogenes and Leishmania major infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Divergent efficacy of antibody to tumor necrosis factor-alpha in intravascular and peritonitis models of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 reduces mortality from severe peritonitis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Critical protective role of mast cells in a model of acute septic peritonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Single-dose tumor necrosis factor protection against endotoxin-induced shock and tissue injury in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

PEG-BP-30 Monotherapy Attenuates the Cytokine-Mediated Inflammatory Cascade in Baboon Escherichia coli Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor antibody treatment of septic baboons reduces the production of sustained T-cell suppressive factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of the biologic activity of tumor necrosis factor maintains vascular endothelial cell function during hyperdynamic sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 1 receptor blockade attenuates the host inflammatory response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 receptor antagonist reduces mortality from endotoxin shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Serum Cytokine Levels in Human Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma tumor necrosis factor in patients with septic shock. Mortality rate, incidence of adult respiratory distress syndrome, and effects of methylprednisolone administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Definition of a new score for severity of generalizedNeisseria meningitidis infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor and septic shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Dissociation between plasma and monocyte-associated cytokines during sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Pattern of soluble TNF receptors I and II in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interactions between cytokines and α2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokine measurements in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Complement activation and the production of inflammatory mediators during the treatment of severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma levels of tumor necrosis factor in the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High bronchoalveolar levels of tumor necrosis factor and its inhibitors, interleukin-1, interferon, and elastase, in patients with adult respiratory distress syndrome after trauma, shock, or sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inflammatory cytokines in the BAL of patients with ARDS. Persistent elevation over time predicts poor outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Expression of tumor necrosis factor-alpha gene in alveolar macrophages from patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Elevated interleukin-1 release by human alveolar macrophages during the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Circulating interleukin-6 receptor in patients with sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Early prediction of outcome in score-identified, postcardiac surgical patients at high risk for sepsis, using soluble tumor necrosis factor receptor-p55 concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monoclonal antibody to TNF in severe septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

CDP571, a humanized antibody to human tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Administration of anti-TNF antibody improves left ventricular function in septic shock patients. Results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. The rhIL-1ra Phase III Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 blockade attenuates mediator release and dysregulation of the hemostatic mechanism during human sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 mediates increased plasma levels of eicosanoids and cytokines in patients with sepsis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A low dose of recombinant interleukin 1 protects granulocytopenic mice from lethal gram-negative infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human chromosome 7 carries the beta 2 interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Haemopoietic receptors and helical cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of an IL-6 signal transducer, gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Ciliary neurotropic factor, interleukin 11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin 6 signal transducer gp130

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of beta 2-interferon by tumor necrosis factor: a homeostatic mechanism in the control of cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 6 is involved in interleukin 1-induced activities

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of rat acute-phase proteins by interleukin 6 in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Multiple actions of interleukin 6 within a cytokine network

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Impaired immune and acute-phase responses in interleukin-6-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Defective inflammatory response in interleukin 6-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Serum levels of interleukin-6 and acute phase responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of neutrophils by recombinant interleukin 6

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide-mediated effects of interleukin-6 on [Ca2+]i and cell contraction in cultured chick ventricular myocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 administration has no acute hemodynamic or hematologic effect in the dog.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

C-reactive protein reactivity with complement and effects on phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Dose-dependent increase in plasma interleukin-6 after recombinant tumour necrosis factor infusion in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of interleukin 6 by human and murine recombinant interleukin 1 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 release during endotoxaemia in chimpanzees: role of platelet-activating factor and interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma neutrophil-activating peptide-1/interleukin-8 and neutrophil elastase in a primate bacteremia model.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of interleukin-6 synthesis in an animal model of septic shock by anti-C5a monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Modification of the anti-CD3-induced cytokine release syndrome by anti-interferon-gamma or anti-interleukin-6 antibody treatment: protective effects and biphasic changes in blood cytokine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent manner by enhancing host defense

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High circulating levels of interleukin-6 in patients with septic shock: Evolution during sepsis, prognostic value, and interplay with other cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cytokine serum level during severe sepsis in human IL-6 as a marker of severity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Changes in granulocyte colony-stimulating factor concentration in patients with trauma and sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Plasma cytokine determinations in emergency department patients as a predictor of bacteremia and infectious disease severity.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Novel neutrophil-stimulating peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The neutrophil-activating proteins interleukin 8 and beta-thromboglobulin: in vitro and in vivo comparison of NH2-terminally processed forms

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning of complementary DNA encoding a functional human interleukin-8 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure and Functional Expression of a Human Interleukin-8 Receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Nitric oxide regulation of IL-8 expression in human endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Thrombin induces GRO alpha/MGSA production in human umbilical vein endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Activated platelets signal chemokine synthesis by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anoxia-hyperoxia induces monocyte-derived interleukin-8

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil activating factor (NAF) induces polymorphonuclear leukocyte adherence to endothelial cells and to subendothelial matrix proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Regulation of Rransendothelial Neutrophil Migration by Endogenous Interleukin-8

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Neutrophil recruitment by intradermally injected neutrophil attractant/activation protein-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL-8 as a circulating cytokine: induction by recombinant tumour necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Essential involvement of interleukin-8 (IL-8) in acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysacchari

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Monocyte chemotactic protein 1 is released during lethal and sublethal bacteremia in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-8 in serum and cerebrospinal fluid from patients with meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Increased levels of circulating interleukin-8 in patients with large burns: relation to burn size and sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 8-related neutrophil elastase and the severity of the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-8 and development of adult respiratory distress syndrome in at-risk patient groups

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Elevated levels of NAP-1/interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Levels of interleukin-8 in patients with adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Role of selectiris In development of adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Macrophage deactivation by interleukin 10

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Divergent effects of interleukin-10 on cytokine production by mononuclear phagocytes and endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 inhibits endotoxin-induced tissue factor mRNA production by human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 inhibits the induction of monocyte procoagulant activity by bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10-deficient mice develop chronic enterocolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 protects mice from lethal endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 production during septicaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 and the monocyte/macrophage-induced inflammatory response in septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High levels of interleukin-10 during the initial phase of fulminant meningococcal septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-10 Is Associated with the Development of Sepsis in Trauma Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 4 prevents the induction of tissue factor mRNA in human monocytes in response to LPS or PMA stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Inhibition of macrophage-activating cytokines is beneficial in the acute septic response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Transforming growth factor-beta and interleukin-10, but not interleukin-4, down-regulate procoagulant activity and tissue factor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Association of Interleukin-4 Plasma Levels With Traumatic Injury and Clinical Course

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Structure of the human immune interferon gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Anti-interferon-gamma antibody protects mice against the generalized Shwartzman reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Essential role for natural killer cells in the lethal lipopolysaccharide-induced Shwartzman-like reaction in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 12: a new clinical player in cytokine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Cloning of a new cytokine that induces IFN-gamma production by T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The role of interleukin 12 in the immune response, disease and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

IL-12 rescues galactosamine-loaded mice from lethal shock triggered by staphylococcal enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon-alpha prevents endotoxin-induced mortality in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

LIF: lots of interesting functions

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of the human homologue of the murine gene encoding myeloid leukemia-inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differentiation factor/leukemia inhibitory factor protection against lethal endotoxemia in mice: synergistic effect with interleukin 1 and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Passive immunization of mice against D factor blocks lethality and cytokine release during endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Induction of cytokine expression by leukemia inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Circulating leukemia inhibitory factor levels correlate with disease severity in meningococcemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Increased plasma levels of human interleukin for DA1.a cells/leukemia inhibitory factor in sepsis correlate with shock and poor prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

MIF as a glucocorticoid-induced modulator of cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Treatment of Cancer Patients with Endotoxin Induces Release of Endogenous Cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of granulocyte colony-stimulating factor on acute lung injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte colony-stimulating factor does not enhance endotoxin-induced acute lung injury in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of recombinant human granulocyte colony-stimulating factor on hemodynamic and cytokine response in a porcine model of Pseudomonas sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of granulocyte colony-stimulating factor on sepsis-induced changes in neutrophil accumulation and organ glucose uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte colony-stimulating factor improves myelopoiesis and host defense in fulminant intra-abdominal sepsis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Effect of granulocyte colony-stimulating factor on systemic and pulmonary responses to endotoxin in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

GM-CSF rapidly primes mice for enhanced cytokine production in response to LPS and TNF

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Granulocyte-macrophage colony-stimulating factor modulates immune function and improves survival after experimental thermal injury

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

The release of interleukin-8 during intravenous bolus treatment with interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Differential priming effects of proinflammatory cytokines on human neutrophil oxidative burst in response to bacterial N-formyl peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-1 (IL-1) receptor antagonist prevents Staphylococcus epidermidis-induced hypotension and reduces circulating levels of tumor necrosis factor and IL-1 beta in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Tumor necrosis factor (TNF)-dependent shedding of the p55 TNF receptor in a baboon model of bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 in biology and medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-6 is required for a protective immune response to systemic Escherichia coli infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Prolonged elevation of interleukin-8 and interleukin-6 concentrations in plasma and of leukocyte interleukin-8 mRNA levels during septicemic and localized Pseudomonas pseudomallei infection

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Alterations of neutrophil responses to tumor necrosis factor alpha and interleukin-8 following human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Interleukin-8 in sepsis: relation to shock and inflammatory mediators

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

High levels of interleukin 10 in serum are associated with fatality in meningococcal disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Treatment of cancer patients with recombinant interferon-gamma induces release of endogenous tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

Role of gamma interferon in a neonatal mouse model of group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2808%2960597-0

7 January 2021

10.1016/S0065-2776(08)60597-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9328641%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference